Enter assignee name

Trademarks = 1

Forward Citations = 22

Loading Chart...

2 inventors (with patents filed for the assignee):

Robert I Henkin (9 out of 19 patents)

Richard Geoffrion (1 out of 1 patent)

9 patents: Sort by Forward Citations

1. 12569493 - Treatment of chemosensory dysfunction from a coronavirus infection (2026-03-10),

2. 12329753 - Phosphodiesterase inhibitor treatment (2025-06-17),

3. 12298316 - Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell (2025-05-13),

4. 11774458 - Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell (2023-10-03),

5. 11389453 - Compositions and methods for treating chemosensory dysfunction (2022-07-19),

6. 11125760 - Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell (2021-09-21),

7. 10598672 - Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell (2020-03-24),

8. 10206927 - Compostions and methods for treating chemosensory dysfunction (2019-02-19),

9. 9719988 - Methods for detection of biological substances (2017-08-01),

Cyrano Therapeutics, Inc. is a biotechnology company focused on developing innovative nasal delivery therapies for central nervous system diseases. Their proprietary technology allows for targeted delivery of therapeutics directly to the brain through the nasal cavity, providing a non-invasive and effective treatment option for patients. The company's mission is to improve the lives of those suffering from neurological disorders by advancing the field of nasal drug delivery.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

9 Patents

#12 in Delray Beach, FL

#970 in Florida

#32,446 in US

Delray Beach, FL, United States of America

Cyrano Therapeutics, Inc.

Forward Citations = 22

2 inventors:

Robert I Henkin (9 out of 19 patents)

Richard Geoffrion (1 out of 1 patent)

Please report any incorrect information to [email protected]